Bitcoin (BTC) has risen roughly 9% this week, indicating solid buying by the bulls. The up move is facing resistance near $69,000 but the bulls are not exiting their positions in a hurry. That ...
Dogecoin (DOGE) remains one of the most closely watched cryptocurrencies, known for its volatility and popularity among ...
In line with our expectations, during the first half of last week ... While, on the upside, the 50-day EMA (Exponential ...
EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...
Novartis' Kisqali receives a positive recommendation from EMA's CHMP for adjuvant treatment of early breast cancer, showing a ...
The European Medicines Agency’s human medicines committee again decided not to recommend the renewal of the conditional ...
AB Science SA (Euronext - FR0010557264 - AB) today announces that the European Medicines Agency (EMA) confirmed a negative opinion for ... often lethal with short term survival or rare or refractory ...
Aptos (APT) surged 24%, but mixed technical signals raise concerns about sustaining the rally, with weakening bullish momentum.
Bitcoin price successfully closes above the $66,000 resistance level, eyeing a rally ahead. Ethereum price bounces off its ...
Bitcoin’s (BTC) rally above $66,500 cleared the final hurdle on its journey to $70,000. According to Farside Investors data, ...
For immediate release Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia ...